BASF Offers Broader Technology Base

BASF’s acquisition of Orgamol more than one year ago significantly boosted BASF’s offering to pharma fine chemical customers, adding a suite of specialist technologies including azide chemistry, low-temperature chemistry, and halogenation reactions, says Martin Widmann, head of BASF’s Pharma Solutions global business unit. The integration of Orgamol into the BASF group is completed, BASF says. Overall sales in BASF’s standard active pharma ingredients business declined during 2006, however, due particularly to a previously announced...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers